Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Can Earnings Narrow The Value Gap In Hewlett Packard?: https://www.marketbeat.com/logos/articles/med_20230531072627_can-earnings-narrow-the-value-gap-in-hewlett-packa.jpg
Can Earnings Narrow The Value Gap In Hewlett Packard?

As the chip and semiconductor industry seems to have found new grounds for revolution, as seen in NVIDIA (NASDAQ: NVDA) sporting its new record one trillion-dollar market cap, other names in the

Palantir: The "Sleeper" Play on the AI Revolution: https://www.marketbeat.com/logos/articles/med_20230530110724_palantir-the-sleeper-play-on-the-ai-revolution.jpg
Palantir: The "Sleeper" Play on the AI Revolution

Nvidia CEO Jensen Huang calls ChatGPT's November 2022 release the AI industry's "iPhone moment," triggering an arms race among tech firms, big and small. Microsoft quickly bought half of OpenAI

Can Tesla's Supercharger Become the Industry Norm? Ford Says Yes: https://www.marketbeat.com/logos/articles/med_20230530105953_can-teslas-supercharger-become-the-industry-norm-f.jpg
Can Tesla's Supercharger Become the Industry Norm? Ford Says Yes

In a move that caught EV industry insiders off guard, Tesla and Ford last week announced a partnership to allow Ford electric vehicle owners to use the Tesla Supercharger networking, comprising

AI Chip Stock Showdown: The Biggest Winners and Losers: https://www.marketbeat.com/logos/articles/med_20230530104818_ai-chip-stock-showdown-the-biggest-winners-and-los.jpg
AI Chip Stock Showdown: The Biggest Winners and Losers

With the AI boom in full swing, many investors are looking to chip makers as the companies that will proverbially sell picks and shovels in the AI gold rush. The thinking goes that the companies

Iovance Biotherapeutics Spikes on Melanoma BLA FDA Application: https://www.marketbeat.com/logos/articles/med_20230530101326_chart-iova.jpg
Iovance Biotherapeutics Spikes on Melanoma BLA FDA Application

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares spiked over 20% on its advanced-stage melanoma treatment application to the U.S. Food and Drug Administration (FDA). The company submitted, and

The Institutions Put A Bottom In Cracker Barrel: https://www.marketbeat.com/logos/articles/med_20230530081156_chart-cbrl-5302023.png
The Institutions Put A Bottom In Cracker Barrel

Cracker  Barrel (NASDAQ: CBRL) stock has been lagging behind its sit-down restaurant peers despite a solid rebound in the industry. Reports from Darden Restaurants International (NYSE: DRI),

Workday: Another AI Winner Melting-Up: https://www.marketbeat.com/logos/articles/med_20230529072846_chart-wday-5292023.png
Workday: Another AI Winner Melting-Up

A melt-up is happening in the tech market, and Workday (NASDAQ: WDAY) is among the early winners. The melt-up is driven by artificial intelligence (AI) and has already produced spectacular gains

Arista Networks Soars As Investors Spot Opportunity After Selloff: https://www.marketbeat.com/logos/articles/med_20230529192544_arista-networks-soars-as-investors-spot-opportunit.jpg
Arista Networks Soars As Investors Spot Opportunity After Selloff

Sometimes when looking at a stock’s chart, you can actually when investors disagree with a selloff. That’s the case with Arista Networks Inc. (NYSE: ANET), which sold off hard after its

The Melt-Up In Marvell Is On; But Don't Chase It Higher: https://www.marketbeat.com/logos/articles/med_20230526091338_chart-mrvl-nvda-5262023.png
The Melt-Up In Marvell Is On; But Don't Chase It Higher

Marvell Technology (NASDAQ: MRVL) started moving higher before the Q1 earnings were released because of results released by NVIDIA (NASDAQ: NVDA). NVIDIA’s results were down compared to last year

Hot Inflation, What It Means For The Summer Rally: https://www.marketbeat.com/logos/articles/med_20230526082818_chart-sp-500-5262023.png
Hot Inflation, What It Means For The Summer Rally

The PCE price index came hotter than expected and will profoundly impact the market. The index accelerated at the core and headline levels and on a month-to-month and YOY basis which can lead to

Ralph Lauren's Styled Dividend Is Still In Season: https://www.marketbeat.com/logos/articles/med_20230525102004_ralph-laurens-styled-dividend-is-still-in-season.jpg
Ralph Lauren's Styled Dividend Is Still In Season

Shares of Ralph Lauren (NYSE: RL) are trading higher on Thursday's trading session, advancing as much as 8.2% amid bullish results from the company's first quarter 2023 earnings. RL stock chart

Upbeat Analysts Project Promising Prospects For Iridium Stock: https://www.marketbeat.com/logos/articles/med_20230525071529_upbeat-analysts-project-promising-prospects-for-ir.jpg
Upbeat Analysts Project Promising Prospects For Iridium Stock

Global satellite communications specialist Iridium Communications Inc. (NASDAQ: IRDM) has a lot going for it. The stock isn't exactly at new heights, but several of its characteristics look

Meet the Nasdaq's 3 Biggest Dividend Payers: https://www.marketbeat.com/logos/articles/med_20230525070240_meet-the-nasdaqs-3-biggest-dividend-payers.jpg
Meet the Nasdaq's 3 Biggest Dividend Payers

The words ‘Nasdaq’ and ‘dividend’ don’t typically go hand in hand. 

It makes sense. The tech-heavy Nasdaq-100 consists largely of cyclical companies that prefer to reinvest profits in growth

Analog Devices Signals A Top For Semiconductor Stocks: https://www.marketbeat.com/logos/articles/med_20230524113233_chart-adi-5242023.png
Analog Devices Signals A Top For Semiconductor Stocks

Analog Devices (NASDAQ: ADI) has been leading the semiconductor market; now, the top is in. The FQ2 results were good enough, but the Q3 guidance is weak and suggests a downturn is coming for the

ZAGENO sichert sich 33-Millionen-Dollar-Finanzierung, um das Beschaffungswesen in der biowissenschaftlichen Forschung zu revolutionieren: https://www.irw-press.at/prcom/images/messages/2023/70699/Zageno_250523_DEPRCOM.002.png
ZAGENO sichert sich 33-Millionen-Dollar-Finanzierung, um das Beschaffungswesen in der biowissenschaftlichen Forschung zu revolutionieren

ZAGENO eröffnet der biowissenschaftlichen Forschung eine bis dato unerreichte Effizienz sowie Kosteneinsparungen

 

CAMBRIDGE, MASSACHUSETTS / ACCESSWIRE / 25. Mai 2023 / ZAGENO, der führende

ZAGENO Secures $33M Funding to Revolutionize Life Science Research Procurement: https://www.irw-press.at/prcom/images/messages/2023/70699/Zageno_250523_PRCOM.002.png
ZAGENO Secures $33M Funding to Revolutionize Life Science Research Procurement

ZAGENO Empowers Life Science Research with Unparalleled Efficiency and Cost Savings

 

CAMBRIDGE, MA / ACCESSWIRE / May 25, 2023 / ZAGENO, the leading online marketplace for life science

Pfizer Has the Prescription for Higher Share Prices: https://www.marketbeat.com/logos/articles/med_20230524125944_pfizer-has-the-prescription-for-higher-share-price.jpg
Pfizer Has the Prescription for Higher Share Prices

Pfizer Inc. (NYSE: PFE) released the results of a peer review study that sent shares up more than 5%. The study evaluated the company’s GLP-1 receptor agonist, danuglipron. The compound aimed to

2 Tech Mid-Caps Under $10 With Big Upside: https://www.marketbeat.com/logos/articles/med_20230524082119_2-tech-mid-caps-under-10-with-big-upside.jpg
2 Tech Mid-Caps Under $10 With Big Upside

This year’s stock market can be summed up in one word — resilient.

On top of inflationary pressures and rising rates, not even government debt ceiling uncertainty has been able to slow the upward

Microbot Medical spikes 150% on its Endovascular Surgical Robot: https://www.marketbeat.com/logos/articles/med_20230523111957_chart-mbot.jpg
Microbot Medical spikes 150% on its Endovascular Surgical Robot

Microbot Medical Inc. (NASDAQ: MBOT) stock spiked more than 150% on a massive 194 million share volume on a successful pre-clinical animal study for its LIBERTY surgical robotic system. Shares hit

BJ's Pulse On Retail Beats Expectations: https://www.marketbeat.com/logos/articles/med_20230523100821_bjs-pulse-on-retail-beats-expectations.jpg
BJ's Pulse On Retail Beats Expectations

BJ's Wholesale Club (NYSE: BJ) reported its first quarter 2023 earnings results on Tuesday morning when the broader stock market index was trading lower by a quarter of a percentage point

Can Lowe’s Lead Discretionary Stocks Lower In 2023?: https://www.marketbeat.com/logos/articles/med_20230523081448_chart-low-5232023.png
Can Lowe’s Lead Discretionary Stocks Lower In 2023?

The Consumer Discretionary Sector ETF (NYSEARCA: XLY) is set up for a reversal, and the outlook is certainly in line with that, but a growing number of reports, including the Q1 report from Lowe’s

Dick’s Sporting Goods Deserves A Higher Price Multiple: https://www.marketbeat.com/logos/articles/med_20230523091047_chart-dks-5232023.png
Doximity is an Overlooked Medical Ecosystem AI Play: https://www.marketbeat.com/logos/articles/med_20230521161256_chart-docs.jpg
Doximity is an Overlooked Medical Ecosystem AI Play

Doximity Inc. (NASDAQ: DOCS) is a digital professional social network platform for medical practitioners. It’s a medical community networking platform like a Microsoft Co. (NASDAQ: MSFT) owned

Can IonQ Be the Leader in Quantum Computing as a Service?: https://www.marketbeat.com/logos/articles/med_20230521162346_chart-ionq.jpg
Can IonQ Be the Leader in Quantum Computing as a Service?

Quantum computing has become a reality as more applications materialize. The viral growth of artificial intelligence (AI) applications driven by the AI battle between Alphabet Inc. (NASDAQ: GOOGL)

Will Dividends Take Center Stage In The Second Half Of 2023?: https://www.marketbeat.com/logos/articles/med_20230522155723_will-dividends-take-center-stage-in-the-second-hal.jpg
Will Dividends Take Center Stage In The Second Half Of 2023?

Plenty of individual stocks are notching outsized gains this year, with S&P 500 leaders Nvidia Corp. (NASDAQ: NVDA) and Meta Platforms Inc. (NASDAQ: META) more than doubling in price. Advanced